{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:24:06Z","timestamp":1787862246875,"version":"build-2784847793"},"update-to":[{"DOI":"10.1002\/14651858.cd009286.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000}}],"reference-count":219,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009286.pub4","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T14:56:33Z","timestamp":1636988193000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery"],"prefix":"10.1002","volume":"2021","author":[{"given":"Lynn A","family":"Legg","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde Health Board; Paisley UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Sofie","family":"Rudberg","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Clinical Sciences; Karolinska Institutet Danderyd Hospital; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Neurology; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology; West China Hospital, Sichuan University; Chengdu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree L","family":"Hackett","sequence":"additional","affiliation":[{"name":"Professor, Program Head, Mental Health; The George Institute for Global Health, Faculty of Medicine, University of New South Wales; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel","family":"Tilney","sequence":"additional","affiliation":[{"name":"Department of Medicine; Mater Dei Hospital; Msida Malta"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"Lindgren","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Neurology; Uppsala University; Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansur A","family":"Kutlubaev","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurosurgery and Medical Genetics; Bashkir State Medical University; Ufa Russian Federation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Fang","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Division of Geriatrics and Gerontology, Department of Internal Medicine and Department of Neurology, Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Barugh","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J","family":"Hankey","sequence":"additional","affiliation":[{"name":"Medical School, Faculty of Health and Medical Sciences,; The University of Western Australia; Perth Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Neurology; Uppsala University; Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dennis","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian E","family":"Mead","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences; University of Edinburgh; Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"10.1002\/14651858.CD009286.pub4-BIB0001|cit1","first-page":"336","article-title":"Serotonergic modulation of brain excitability and motor recovery in patients affected by stroke. A double blind placebo RCT","volume":"3","author":"Acler","year":"2008","journal-title":"International Journal of Stroke"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00415-009-5093-7","article-title":"A double blind placebo RCT to investigate the effects of serotonergic modulation on brain excitability and motor recovery in stroke patients","volume":"256","author":"Acler","year":"2009","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0003|cit3","unstructured":"Assessment of fluoxetine in stroke recovery (AFFINITY) trial, 2011 www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12611000774921"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0004|cit4","unstructured":"The assessment of fluoxetine in stroke recovery imaging and blood biomarkers sub-study AFFINITY BM www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx ?ACTRN=12619000986178"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1474-4422(20)30207-6","article-title":"Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial","volume":"19","author":"AFFINITY Trial Collaboration","year":"2020","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0006|cit6","unstructured":"Hankey G Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) www.affinitytrial.org\/"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.4088\/JCP.v67n0713","article-title":"Preventing depression after stroke: results from a randomized placebo-controlled trial","volume":"67","author":"Almeida","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0008|cit8","first-page":"S42","article-title":"Effective treatment of post-stroke depression with selective serotonin reuptake inhibitors","volume":"241","author":"Andersen","year":"1994","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/01.STR.25.6.1099","article-title":"Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram","volume":"25","author":"Andersen","year":"1994","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0010|cit10","first-page":"20","article-title":"Post-stroke depression treated with citalopram","volume":"89 Suppl 155","author":"Andersen","year":"1994","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0011|cit11","first-page":"S115","article-title":"Post-stroke depression treated with citalopram - a selective serotonin reuptake inhibitor","volume":"20","author":"Andersen","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0012|cit12","unstructured":"Andersen G Vestergaard K Lauritzen L Post-stroke depression treated with citalopram a selective serotonin reuptake inhibitor 7th Scandinavian Meeting on Cerebrovascular Disease 1993 54"},{"issue":"14","key":"10.1002\/14651858.CD009286.pub4-BIB0013|cit13","first-page":"2000","article-title":"Effective treatment of depression following apoplexy with citalopram","volume":"157","author":"Andersen","year":"1995","journal-title":"Ugeskrift for Laeger"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0014|cit14","unstructured":"Flicker C Andersen G Bayer L A placebo controlled study of citalopram treatment for post-stroke depression 11th Annual Meeting of the American Association for Geriatric Psychiatry 1998"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0015|cit15","unstructured":"Andersen G The efficacy of citalopram treatment in acute stroke (TALOS) www.clinicaltrials.gov\/ct2\/show\/NCT01937182"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1159\/000511490","article-title":"Prestroke physical activity and poststroke cognitive performance","volume":"49","author":"Damsbo","year":"2020","journal-title":"Cerebrovascular Diseases"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.117.020067","article-title":"Neuroregeneration and vascular protection by citalopram in acute ischemic stroke (TALOS)","volume":"49","author":"Kraglund","year":"2018","journal-title":"Stroke"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/STROKEAHA.117.020067","article-title":"Neuroregeneration and vascular protection by citalopramin in acute ischemic stroke (TALOS)","volume":"49","author":"Kraglund","year":"2018","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/ijs.12485","article-title":"TALOS: a multicenter, randomised, double blind, placebo controlled trial to test the effects of citalopram in patients with acute stroke; protocol","volume":"10","author":"Kraglund","year":"2015","journal-title":"International Journal of Stroke"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"200482019","DOI":"10.1038\/s41598-019-56487-8","article-title":"Antiplatelet effects of citalopram in patients with ischaemic stroke: a randomized, placebo-controlled, double-blind study","volume":"9","author":"Kraglund","year":"2019","journal-title":"Scientific Reports"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/0269215518777791","article-title":"The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial","volume":"32","author":"Asadollahi","year":"2018","journal-title":"Clinical Rehabilitation"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.5603\/PJNNS.a2020.0099","article-title":"Fluoxetine for stroke recovery improvement - the doubleblind, randomised placebo-controlled FOCUS-Poland trial","volume":"54","author":"Bembenek","year":"2020","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0023|cit23","unstructured":"Fluoxetine or control under supervision: Poland Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products - EduraCT No: 2014-001335-37 2014"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neucli.2018.10.065","article-title":"Individual recovery profiles of manual dexterity, and relation to corticospinal lesion load and excitability after stroke - a longitudinal pilot study","volume":"49","author":"Birchenall","year":"2019","journal-title":"Neurophysiologie Clinique"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0025|cit25","unstructured":"Evaluation by transcranial magnetic stimulation of the benefit of fluoxetine on motor recovery after stroke (EFLUSTIM) clinicaltrials.gov\/ct2\/show\/NCT02063425"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0447.1998.tb10119.x","article-title":"Fluoxetine as a treatment for post-stroke emotionalism","volume":"98","author":"Brown","year":"1998","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z","article-title":"Sertraline in stroke-associated lability of mood","volume":"14","author":"Burns","year":"1999","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"e8930","DOI":"10.1590\/1414-431x20208930","article-title":"Effects of the prophylactic use of escitalopram on the prognosis and the plasma copeptin level in patients with acute cerebral infarction","volume":"53","author":"Cao","year":"2020","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3233\/RNN-201041","article-title":"Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction","volume":"38","author":"Cao","year":"2020","journal-title":"Restorative Neurology and Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0030|cit30","first-page":"20","article-title":"Study of effect of integrative Chinese herbs with fluoxetine on rehabilitation of neurological impairment in patients with post-stroke depression","volume":"24","author":"Chen","year":"2001","journal-title":"Journal of Chengdu University of Traditional Chinese Medicine"},{"issue":"13","key":"10.1002\/14651858.CD009286.pub4-BIB0031|cit31","first-page":"2014","article-title":"Effects of paroxetine on function recovery in patients with post-stroke depression","volume":"6","author":"Chen","year":"2002","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"16","key":"10.1002\/14651858.CD009286.pub4-BIB0032|cit32","first-page":"118","article-title":"Changes of neurotransmitter in patients with post-stroke depression observed with encephalofluctuography technology","volume":"9","author":"Chen","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0033|cit33","first-page":"382","article-title":"A study on paroxetine in the treatment for post-stroke depression","volume":"40","author":"Chen","year":"2005","journal-title":"Jiangxi Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0034|cit34","first-page":"97","article-title":"Clinical efficacy of drug intervention in patients with acute depression after stroke","volume":"42","author":"Chen","year":"2015","journal-title":"International Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0035|cit35","first-page":"108","article-title":"Study of effect on neurologic function rehabilitation in patient with post-stroke depression","volume":"7","author":"Cheng","year":"2003","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(10)70314-8","article-title":"Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial","volume":"10","author":"Chollet","year":"2011","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.STR.27.7.1211","article-title":"Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy","volume":"27","author":"Dam","year":"1996","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0038|cit38","unstructured":"Dike F Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine www.pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=967"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15406\/jnsk.2019.09.00346","article-title":"Pharmacological enhancement of motor function recovery in patients with ischaemic stroke: a trial of fluoxetine","volume":"9","author":"Dike","year":"2019","journal-title":"Journal of Neurology and Stroke"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(20)30219-2","article-title":"Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial","volume":"19","author":"EFFECTS Trial Collaboration","year":"2020","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0041|cit41","unstructured":"Establishing the effect(s) and safety of fluoxetine initiated in the acute phase of stroke www.isrctn.com\/ISRCTN13020412"},{"issue":"388","key":"10.1002\/14651858.CD009286.pub4-BIB0042|cit42","first-page":"s13063","article-title":"Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden","volume":"21","author":"Lundstr\u00f6m","year":"2020","journal-title":"Trials"},{"issue":"233","key":"10.1002\/14651858.CD009286.pub4-BIB0043|cit43","first-page":"s13063","article-title":"Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden","volume":"21","author":"Lundstr\u00f6m","year":"2020","journal-title":"Trials"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"661-9","DOI":"10.1016\/S1474-4422(20)30219-2","article-title":"Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial","volume":"19","author":"Lundstrom","year":"2020","journal-title":"Lancet Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3736\/jcim20040309","article-title":"Influence of Jieyu Huoxue decoction on rehabilitation of patients with depression after cerebral infarction","volume":"2","author":"Zheng-Yuan","year":"2004","journal-title":"Journal of Chinese Integrated Medicine"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0046|cit46","unstructured":"The FOCUS (Fluoxetine or Control under Supervision) trial results: effects of a 6 month course of fluoxetine on the Stroke Impact Scale, mood and fatigue in patients with stroke www.ed.ac.uk\/clinical-brain-sciences\/research\/completed-studies-trials\/focus-stroke-trial"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/bmj.l1029","article-title":"Does fluoxetine improve recovery after stroke?","volume":"364","author":"Cook","year":"2019","journal-title":"BMJ"},{"issue":"22","key":"10.1002\/14651858.CD009286.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24220","article-title":"Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT","volume":"24","author":"Dennis","year":"2020","journal-title":"Health Technology Assessment"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/STROKEAHA.119.026639","article-title":"Fluoxetine and fractures after stroke: exploratory analyses from the FOCUS Trial","volume":"50","author":"Dennis","year":"2019","journal-title":"Stroke"},{"issue":"10168","key":"10.1002\/14651858.CD009286.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(18)32823-X","article-title":"Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial","volume":"393","author":"FOCUS Trial Collaboration","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/s13063-017-2385-6","article-title":"The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical and health economic analysis plan for the trials and for the individual patient data meta-analysis","volume":"18","author":"Graham","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0052|cit52","first-page":"7142019","article-title":"The effects of fluoxetine on fracture risk after stroke: Further analyses from the focus trial","volume":"4 suppl 1","author":"Lundstrom","year":"2019","journal-title":"European Stroke Journal"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"e0404922020","DOI":"10.1136\/bmjopen-2020-040492","article-title":"Feasibility of reporting results of large randomised controlled trials to participants: experience from the Fluoxetine or Control under Supervision (FOCUS) trial","volume":"10","author":"Mead","year":"2020","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0054|cit54","unstructured":"Mead G Fluoxetine Or Control Under Supervision (FOCUS) trial: to establish the effect(s) of routine administration of Fluoxetine in patients with a recent stroke www.isrctn.com\/ISRCTN83290762"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Mead GE Dennis MS Innes K MacLeod M Sandercock PA House A A multicentre randomised trial to establish the effect(s) of routine administration of fluoxetine in patients with a recent stroke (Fluoxetine Or Control Under Supervision, FOCUS) 21st European Stroke Conference 2012 Abst OAID 26","DOI":"10.1186\/ISRCTN83290762"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1186\/s13063-020-04875-1","article-title":"Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis","volume":"21","author":"Mead","year":"2020","journal-title":"Trials"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/1747493019879655","article-title":"Fluoxetine for stroke recovery: meta-analysis of randomized controlled trials","volume":"15","author":"Mead","year":"2020","journal-title":"International Journal of Stroke"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00415-003-1014-3","article-title":"Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled study with an open-label long-term follow up","volume":"250","author":"Fruehwald","year":"2003","journal-title":"Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/0269215515626232","article-title":"Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke","volume":"31","author":"Gao","year":"2017","journal-title":"Clinical Rehabilitation"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0060|cit60","unstructured":"An 8-week double-blind placebo controlled parallel group study to assess the efficacy and tolerability of paroxetine in patients suffering from depression following stroke GSK Clinical Study Register www.gsk clinicalstudyregister.com"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"101102","DOI":"10.1016\/j.eujim.2020.101102","article-title":"The efficacy of integrative anti-depressive therapy on motor recovery after ischemic stroke: a randomized clinical trial","volume":"35","author":"Gong","year":"2020","journal-title":"European Journal of Integrative Medicine"},{"issue":"10","key":"10.1002\/14651858.CD009286.pub4-BIB0062|cit62","first-page":"785","article-title":"Effects of Linggui Bafa on the therapeutic effect and quality of life in patients of post-stroke depression","volume":"29","author":"Su","year":"2009","journal-title":"Chinese Acupuncture & Moxibustion"},{"issue":"28","key":"10.1002\/14651858.CD009286.pub4-BIB0063|cit63","first-page":"6016","article-title":"Randomized controlled observation on the effect of early application of fluoxetine in preventing depression after stroke","volume":"8","author":"He","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0064|cit64","first-page":"6","article-title":"Prospective study of effects of paroxetine with mental intervention on depression and anxiety after stroke","volume":"5","author":"He","year":"2005","journal-title":"Nervous Diseases and Mental Health"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0065|cit65","first-page":"564","article-title":"A clinical trial of paroxetine and psychotherapy in patients with post-stroke depression and anxiety","volume":"19","author":"Wang","year":"2005","journal-title":"Chinese Mental Health Journal"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0066|cit66","unstructured":"Multi-center randomized clinical study of antidepressant treatment (fluoxetine) on secondary prevention of ischemic stroke www.chictr.org.cn\/showprojen.aspx?proj=7471"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/RNN-150535","article-title":"Effect of using fluoxetine at different time windows on neurological functional prognosis after ischaemic stroke","volume":"34","author":"Guo","year":"2016","journal-title":"Restorative Neurology and Neuroscience"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2018.02.029","article-title":"Effect of fluoxetine on three-year recurrence in acute ischemic stroke: a randomized controlled clinical study","volume":"168","author":"He","year":"2018","journal-title":"Clinical Neurology and Neurosurgery"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.11.035","article-title":"Effects of fluoxetine on neural functional prognosis after ischemic stroke: a randomized controlled study in China","volume":"25","author":"Jiang","year":"2016","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0070|cit70","first-page":"149","article-title":"The comparative study of the effectiveness of fluoxetine on the stroke patients with depressive symptoms","volume":"14","author":"Hu","year":"2002","journal-title":"Shanghai Archives of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0071|cit71","first-page":"325","article-title":"Effects of escitalopram on post-stroke depression and cognitive function of patients with neurological function","volume":"24","author":"Hu","year":"2018","journal-title":"Hebei Medicine"},{"issue":"15","key":"10.1002\/14651858.CD009286.pub4-BIB0072|cit72","first-page":"2296","article-title":"The clinical correlation study and the effect of fluoxetine intervention on poststroke depression","volume":"6","year":"2002","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"12","key":"10.1002\/14651858.CD009286.pub4-BIB0073|cit73","first-page":"4","article-title":"Effect of early intervention on recovery of motor function and recurrent stroke in patients with post-stroke depression","volume":"9","author":"Jia","year":"2005","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2215-0366(16)30417-5","article-title":"Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study","volume":"4","author":"Kim","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5853\/jos.2017.02712","article-title":"Differences in therapeutic responses and factors affecting post-stroke depression at a later stage according to baseline depression","volume":"20","author":"Lee","year":"2018","journal-title":"Journal of Stroke"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0076|cit76","first-page":"891988720957108","article-title":"Post-stroke depressive symptoms: varying responses to escitalopram by individual symptoms and lesion location","volume":"10","author":"Lee","year":"2020","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jnnp-2017-316882","article-title":"Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use","volume":"89","author":"Lee","year":"2018","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0078|cit78","unstructured":"The preventative effect of escitalopram on depression and related emotional disorders in acute stroke patients, 2011 clinicaltrials.gov\/ct2\/show\/NCT01278498"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1673-5374(07)60036-X","article-title":"Fluoxetine for poststroke depression: a randomized placebo controlled clinical trial","volume":"2","author":"Kong","year":"2007","journal-title":"Neural Regeneration Research"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0080|cit80","first-page":"585","article-title":"The effect of using paroxetine to treat post stroke depression","volume":"24","author":"Lai","year":"2006","journal-title":"Journal of Guangdong Medical College"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0081|cit81","first-page":"1208","article-title":"Recent effect of fluoxetine in improving neurologic impairment and preventing post-stroke depression in the early stage","volume":"8","author":"Li","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"19","key":"10.1002\/14651858.CD009286.pub4-BIB0082|cit82","first-page":"3713","article-title":"Effect of antidepressant drugs in early period on the recovery of post-stroke depression","volume":"8","author":"Liao","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0083|cit83","first-page":"209","article-title":"Related factors of post-stroke depression and effect of paroxetine","volume":"18","author":"Li","year":"2005","journal-title":"Shandong Archives of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0084|cit84","first-page":"275","article-title":"The efficacy of citalopram for post-stroke depression and its effects on stroke rehabilitation","volume":"14","year":"2006","journal-title":"International Journal of Cerebrovascular Diseases"},{"issue":"34","key":"10.1002\/14651858.CD009286.pub4-BIB0085|cit85","first-page":"5103","article-title":"Clinical efficacy of paroxetine in the treatment of post-stroke depression","volume":"16","author":"Li","year":"2007","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/acm.2008.0010","article-title":"The beneficial effects of the herbal medicine free and easy wanderer plus (FEWP) and fluoxetine on post-stroke depression","volume":"14","author":"Chen","year":"2008","journal-title":"Journal of Alternative and Complementary Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0087|cit87","first-page":"589","article-title":"Effects of escitalopram oxalate on post-stroke depression, cognition and neurological function","volume":"38","author":"Li","year":"2017","journal-title":"Journal of Hebei Medical University"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0088|cit88","first-page":"174","article-title":"Effect of citalopram treatment on post-stroke depression and neurological functional rehabilitation","volume":"21","author":"Liu","year":"2006","journal-title":"Chinese Journal of Rehabilitation"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1745-6215-14-77","article-title":"Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH): study protocol for a randomized, double-blind, placebo-controlled, multicenter trial","volume":"14","author":"Marquez-Romero","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"105656","DOI":"10.1016\/j.clineuro.2019.105656","article-title":"Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH trial","volume":"190","author":"Marquez-Romero","year":"2020","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0091|cit91","unstructured":"Marquez-Romero JM Reyes-Mart\u00ednez M Huerta-Franco MR Ruiz-Franco A Silos H Arauz A Fluoxetine for motor recovery after acute intracerebral hemorrhage, the FMRICH Trial Correspondence from Marquez-Romero 2018"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0092|cit92","unstructured":"Marquez-Romero JM Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH) www.clinicaltrials.gov\/ct2\/show\/NCT01737541"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0093|cit93","first-page":"90","article-title":"The treatment of depression after stroke with the selective serotonin reuptake inhibitor sertraline","volume":"8 Suppl 4","author":"Meara","year":"1998","journal-title":"Cerebrovascular Diseases"},{"issue":"19","key":"10.1002\/14651858.CD009286.pub4-BIB0094|cit94","first-page":"3718","article-title":"Related factors of post-stroke depression and therapeutical effect of citalopram","volume":"8","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"708","DOI":"10.4088\/JCP.v66n0606","article-title":"Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression","volume":"66","author":"Murray","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0096|cit96","unstructured":"Setraline for prevention post stroke depression and improving rehabilitation outcomes clinicaltrials.gov\/ct2\/show\/NCT00177424"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0097|cit97","unstructured":"Fluoxetine for motor, aphasia, and neglect recovery after ischemic stroke (FLAN) www.clinicaltrials.gov\/ct2\/show\/NCT01674868"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0098|cit98","unstructured":"Fluoxetine for visual recovery after ischaemic stroke (FLUORESCE) www.clinicaltrials.gov\/ct2\/show\/NCT02737930"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0099|cit99","doi-asserted-by":"crossref","unstructured":"Cheng X Effects of paroxetine on motor and cognitive function recovery in patients with non-depressed ischemic stroke: an open randomized controlled study Brain Impairment doi: 10.1017\/BrImp.2018.6","DOI":"10.1017\/BrImp.2018.6"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0001-4079(19)34246-3","article-title":"Rehabilitation after stroke","volume":"6","author":"Guiraud-Chaumeil","year":"2002","journal-title":"Bulletin de l'Acad\u00e9mie Nationale de M\u00e9decine"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.1257","article-title":"Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke","volume":"50","author":"Pariente","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0924-977X(02)80275-9","article-title":"A double-blind placebo controlled study of sertraline in the prevention of depression in stroke patients","volume":"12","author":"Rasmussen","year":"2002","journal-title":"European Neuropyschopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.psy.44.3.216","article-title":"A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients","volume":"44","author":"Rasmussen","year":"2003","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0104|cit104","first-page":"288","article-title":"Depression and stroke","volume":"55","author":"Rasmussen","year":"2001","journal-title":"Nordic Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0105|cit105","first-page":"66","article-title":"Prophylactic treatment for post-stroke depression and comorbidity","volume":"48","author":"Rasmussen","year":"2000","journal-title":"Journal of Psychosomatic Research"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"e75492016","DOI":"10.17795\/zjrms-7549","article-title":"Effect of fluoxetine on motor improvement in ischemic stroke patients: a double blind clinical trial study","volume":"18","author":"Razazian","year":"2016","journal-title":"Zahedan Journal of Research in Medical Sciences"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0107|cit107","unstructured":"Razazian N A survey for assessment of effectiveness of fluoxetine on motor improvement in ischemic stroke patients www.en.irct.ir\/trial\/8797"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0108|cit108","first-page":"284","article-title":"Motor cortex reorganization induced by fluoxetine in poststroke hemiplegic patients undergoing rehabilitation therapy: a study with transcranial magnetic stimulation","volume":"15","author":"Restifo","year":"2001","journal-title":"Neurorehabilitation and Neural Repair"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1176\/appi.ajp.160.10.1823","article-title":"Mortality and post-stroke depression: a placebo controlled trial of antidepressants","volume":"160","author":"Jorge","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005053-200205000-00005","article-title":"Preventing post-stroke depression: a 12 week double blind randomised treatment trial and 21 month follow-up","volume":"190","author":"Narushima","year":"2002","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/appi.ajp.157.3.351","article-title":"Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study","volume":"157","author":"Robinson","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1176\/appi.ajp.160.10.1823","article-title":"Mortality and post-stroke depression: a placebo controlled trial of antidepressants","volume":"160","author":"Jorge","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/00005053-200205000-00005","article-title":"Preventing post-stroke depression: a 12 week double blind randomised treatment trial and 21 month follow-up","volume":"190","author":"Narushima","year":"2002","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1176\/appi.ajp.157.3.351","article-title":"Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study","volume":"157","author":"Robinson","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archgenpsychiatry.2009.185","article-title":"Escitalopram and enhancement of cognitive recovery following stroke","volume":"67","author":"Jorge","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jama.2009.256","article-title":"Incomplete financial disclosure in a study of escitalopram and problem solving therapy for prevention of post-stroke depression","volume":"301","author":"Robinson","year":"2009","journal-title":"JAMA"},{"issue":"20","key":"10.1002\/14651858.CD009286.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.299.20.2391","article-title":"Escitalopram and problem-solving therapy for prevention of poststroke depression","volume":"299","author":"Robinson","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/1545968317704902","article-title":"Efficacy of citalopram on acute ischemic stroke outcome: a randomized clinical trial","volume":"31","author":"Savadi Oskouie","year":"2017","journal-title":"Neurorehabilitation and Neural Repair"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0119|cit119","unstructured":"Savadi Oskouie D Evaluation of the effect of citalopram on three months functional prognosis of acute ischemic stroke patients: a randomized clinical trial www.en.irct.ir\/trial\/1766"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0120|cit120","unstructured":"Shah IA Asimi RP Kawoos Y Wani MA Wani MA Dar MA Effect of fluoxetine on motor recovery after acute haemorrhagic stroke: a randomized trial Journal of Neurology and Neurophysiology 2016 7 2 10.4172\/2155-9562.1000364"},{"issue":"14","key":"10.1002\/14651858.CD009286.pub4-BIB0121|cit121","first-page":"160","article-title":"Effects of fluoxetine hydrochloride on depressive symptoms and P300 after cerebral stroke","volume":"10","year":"2006","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0122|cit122","first-page":"270","article-title":"The effects of anti-depression therapy on post-stroke depression and neurologic rehabilitation in the elderly patients","volume":"22","author":"Wang","year":"2003","journal-title":"Chinese Journal of Geriatrics"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0123|cit123","first-page":"11","article-title":"The efficacy of paroxetine in the treatment of post-stroke depression in 55 cases","volume":"11","author":"Wang","year":"2009","journal-title":"Chinese Community Physician (Medical Professional Half-monthly)"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0124|cit124","first-page":"253","article-title":"The influence of post-stroke prophylactic anti-depression treatment on nerve functional rehabilitation","volume":"42","year":"2006","journal-title":"Acta Academiae Medicinae Qingdao Universitatis"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.STR.31.8.1829","article-title":"Fluoxetine in early poststroke depression: a double-blind placebo-controlled study","volume":"31","author":"Wiart","year":"2000","journal-title":"Stroke"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0126|cit126","first-page":"294","article-title":"A prospective random clinical contrast study of treatment with sertraline in elderly patients with post-stroke depression","volume":"13","author":"Xie","year":"2005","journal-title":"Chinese Journal of Clinical Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0127|cit127","first-page":"281","article-title":"A study on treatment of fluoxetine to depression in early recovery stage of cerebral infarction","volume":"16","author":"Xu","year":"2001","journal-title":"Chinese Journal of Rehabilitation Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0128|cit128","first-page":"186","article-title":"Preventive effects of antidepressants on post-stroke depression","volume":"20","author":"Xu","year":"2006","journal-title":"Chinese Mental Health Journal"},{"issue":"12","key":"10.1002\/14651858.CD009286.pub4-BIB0129|cit129","first-page":"871","article-title":"Controlled study on antidepressant treatment of patients with post-stroke depression","volume":"16","author":"Yang","year":"2002","journal-title":"Chinese Mental Health Journal"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0130|cit130","first-page":"235","article-title":"Therapeutic effect of paroxetine on patients with early poststroke depression and the serum interleukins","volume":"8","author":"Yang","year":"2011","journal-title":"Chinese Journal of Cerebrovascular Diseases"},{"issue":"31","key":"10.1002\/14651858.CD009286.pub4-BIB0131|cit131","first-page":"6826","article-title":"Effect of anti-depressive therapy on the rehabilitation of psychological and neurological function after stroke","volume":"8","author":"Wang","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"6","key":"10.1002\/14651858.CD009286.pub4-BIB0132|cit132","first-page":"153","article-title":"Effect of paxil and berhomine on post-stroke anxiety-depression and neurological recovery","volume":"10","author":"Ye","year":"2006","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0133|cit133","first-page":"55","article-title":"Effects of antidepressants on neurofunctional recovery of post-stroke patients with aphasia","volume":"33","author":"Zhao","year":"2011","journal-title":"Journal of Dalian Medical University"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0134|cit134","first-page":"263","article-title":"Preventive effects of fluoxetine on post-stroke depression","volume":"25","year":"2008","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0135|cit135","unstructured":"FRAMBOISE: Fluoxetine, Recovery And Motor BiOmarkers In StrokE https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=377306"},{"issue":"8875","key":"10.1002\/14651858.CD009286.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0140-6736(93)92696-Q","article-title":"Citalopram for post-stroke pathological crying","volume":"342","author":"Andersen","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0137|cit137","unstructured":"Andersen G Efficacy of escitalopram treatment in acute stroke and the role of specific genotypes in stroke www.clinicaltrialsregister.eu\/ctr-search\/search?query=2011-005541-12"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0138|cit138","unstructured":"Andersen G Escitalopram Treatment In Acute Stroke (ESTIAS) www.clinicaltrials.gov\/ct2\/show\/NCT01561092"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0139|cit139","first-page":"79","article-title":"Maximising outcome by overcoming depression in stroke (MOODS) trial","volume":"13 Suppl 3","author":"Anderson","year":"2002","journal-title":"Cerebrovascular Diseases 2002"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0140|cit140","first-page":"3","article-title":"Stroke and depression","volume":"23","year":"2012","journal-title":"Johns Hopkins Medical Letter: Health After 50"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0141|cit141","first-page":"5","article-title":"Drug & Device News","volume":"30","year":"2012","journal-title":"Medical Malpractice Law & Strategy, New York Law Journal Newsletters"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WNF.0b013e3181633482","article-title":"Single dose of fluoxetine increases muscle activation in chronic stroke patients","volume":"32","author":"Berends","year":"2009","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/1545968319860483.","article-title":"Combining fluoxetine and rTMS in poststroke motor recovery: a placebo-controlled double-blind randomized phase 2 clinical trial","volume":"33","author":"Bonin Pinto","year":"2019","journal-title":"Neurorehabilitation and Neural Repair"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0144|cit144","unstructured":"Effects rTMS combined with fluoxetine on motor recovery in stroke patients www.clinicaltrials.gov\/ct2\/show\/NCT02208466"},{"issue":"29","key":"10.1002\/14651858.CD009286.pub4-BIB0145|cit145","first-page":"1","article-title":"Effectiveness of paroxetine in the treatment of poststroke depression","volume":"97","author":"Ping","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000147454","article-title":"Fluoxetine improves the quality of life in patients with poststroke emotional disturbances","volume":"26","author":"Choi-Kwon","year":"2008","journal-title":"Cerebrovascular Diseases"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00115-008-2649-1","article-title":"Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness","volume":"80","author":"Finkenzeller","year":"2009","journal-title":"Der Nervenarzt"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0148|cit148","first-page":"36","article-title":"FLOW Trial: fluoxetine to open the critical period time window to improve motor recovery after stroke","volume":"14 Suppl 3","author":"Foster","year":"2019","journal-title":"International Journal of Stroke"},{"issue":"12","key":"10.1002\/14651858.CD009286.pub4-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.apmr.2015.08.431","article-title":"Increased lower limb spasticity but not strength or function following a single-dose serotonin reuptake inhibitor in chronic stroke","volume":"96","author":"Gourab","year":"2015","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0150|cit150","unstructured":"Graffagnino C Poststroke depression and functional recovery (SADBRAIN) Duke University Medical Centre 2002"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0151|cit151","first-page":"329","article-title":"Efficacy of fluoxetine in the treatment of 20 patients with depression after stroke","volume":"19","author":"Ji","year":"2000","journal-title":"Herald of Medicine"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0152|cit152","unstructured":"Dose-finding study of selective serotonin reuptake inhibitors to enhance neuroplasticity Source not provided from searches 2020"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0153|cit153","first-page":"11","article-title":"Effect of paroxetine on prognosis of patients with post cerebral infarction depression","volume":"21","author":"Li","year":"2002","journal-title":"Chinese Journal of New Drugs and Clinical Remedies."},{"issue":"13","key":"10.1002\/14651858.CD009286.pub4-BIB0154|cit154","first-page":"1924","article-title":"Clinical efficacy of fluoxetine in treatment of patients with depression after acute stroke","volume":"7","author":"Liang","year":"2003","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"30","key":"10.1002\/14651858.CD009286.pub4-BIB0155|cit155","first-page":"6600","article-title":"Recent effect of drug intervention on post-stroke anxiety","volume":"8","year":"2004","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"10","key":"10.1002\/14651858.CD009286.pub4-BIB0156|cit156","first-page":"7881","article-title":"Study on the efficacy and mechanism of paroxetine hydrochloride combined with repetitive transcranial magnetic stimulation in the treatment of post-stroke depression","volume":"13","author":"Liu","year":"2020","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0157|cit157","first-page":"118","article-title":"Studying effect of fluoxetine on improvement of motor performance in patients with ischemic stroke","volume":"6","author":"Mosarrezaii","year":"2018","journal-title":"Journal of Research in Medical and Dental Sciences"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0158|cit158","unstructured":"RCT of a neuroplasticity agent and CI therapy for severe arm paresis after stroke clinicaltrials.gov\/ct2\/show\/NCT01963832"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0159|cit159","first-page":"18","article-title":"Prevention of anxiety disorder after stroke","volume":"23","author":"Robinson","year":"2011","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0160|cit160","first-page":"651","article-title":"Prevention of poststroke depression after acute ischemic stroke using the selective serotonin reuptake inhibitor sertraline (PreDis-study)","volume":"33","author":"Sitzer","year":"2002","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0161|cit161","first-page":"119","article-title":"Efficacy observation on the treatment of post-stroke depression by acupuncture at the acupoints based on ziwuliuzhu and Prozac","volume":"355","author":"Sun","year":"2015","journal-title":"Chinese Acupuncture and Moxibustion"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"116563","DOI":"10.1016\/j.jns.2019.116563","article-title":"MAMBO: Measuring Ambulation, Motor, and Behavioral Outcomes with post-stroke fluoxetine in Tanzania: protocol of a phase II clinical trial","volume":"408","author":"Vogel","year":"2020","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1002\/14651858.CD009286.pub4-BIB0163|cit163","first-page":"640","article-title":"Observation of effect of Wulung capsule in treating post-stroke depression","volume":"27","author":"Xu","year":"2007","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0164|cit164","first-page":"374","article-title":"Effects of fluoxetine on neurofunctional recovery of non depressed patients after stroke","volume":"7","author":"Zhou","year":"2003","journal-title":"Chinese Journal of Clinical Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD009286.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"177-87","DOI":"10.3233\/RNN-150535","article-title":"Effect of using fluoxetine at different time windows on neurological functional prognosis after ischemic stroke","volume":"34","author":"Guo","year":"2016","journal-title":"Restorative Neurology and Neuroscience"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0166|cit166","unstructured":"Guo Y Effect of using fluoxetine at different time windows after ischemic stroke on neurological functional prognosis: a randomized controlled trial chictr.org.cn\/showprojen.aspx?proj=12925"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0167|cit167","unstructured":"Multi-center randomized clinical study of antidepressant treatment (fluoxetine) on secondary prevention of ischemic stroke www.chictr.org.cn\/showprojen.aspx?proj=7471"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clineuro.2018.02.029","article-title":"Effect of fluoxetine on three-year recurrence in acute ischemic stroke: a randomized controlled clinical study","volume":"168","author":"He","year":"2018","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0169|cit169","first-page":"614","article-title":"Improved post-ischaemic stroke recovery over 1 year with escitalopram for 3 months","volume":"23","author":"Jurcau","year":"2016","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0170|cit170","unstructured":"Effects of clinical and functional outcome of escitalopram in adult stroke patients clinicaltrials.gov\/ct2\/show\/NCT00967408"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0171|cit171","unstructured":"The effect and mechanism of fluoxetine on the automatic regulation of cerebral blood flow for ischemic stroke https:\/\/www.chictr.org.cn\/showprojen.aspx?proj=32801"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0172|cit172","unstructured":"An interventional study to look at efficacy of fluoxetine in patients with post-stroke anxiety http:\/\/ctri.nic.in CTRI\/2018\/12\/016568"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0173|cit173","unstructured":"Influence of escitalopram on the incidence of depression and dementia following acute middle cerebral artery territory infarction. A randomised placebo-controlled double blind study www.clinicaltrialsregister.eu\/ctr-search\/search?query=2005-005266-37"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0174|cit174","unstructured":"Effect of fluoxetine on functional recovery of patients with cerebrovascular accident following middle cerebral artery trunk obstruction: a randomized clinical trial www.en.irct.ir\/trial\/8954"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0175|cit175","unstructured":"A study of sertraline effect on quality of life in stroke inpatients www.en.irct.ir\/trial\/11413"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0176|cit176","unstructured":"Evaluation of fluoxetine and standard treatment efficacy on change to side effect of stroke of ischemic strokes in both hemispheres in anterior circulation www.irct.ir\/trial\/17976"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0177|cit177","unstructured":"The efficacy comparison of fluoxetine and citalopram on motor recovery after ischemic stroke: single-blind placebo-controlled randomized clinical trial https:\/\/en.irct.ir\/trial\/54896"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0178|cit178","unstructured":"Effect of serotonin and levodopa in ischemic stroke www.clinicaltrials.gov\/ct2\/show\/NCT02386475"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0179|cit179","unstructured":"Serotonin Selective Reuptake Inhibitor (SSRI) effects on cerebral connectivity in acute ischemic stroke (RECONISE) www.clinicaltrials.gov\/ct2\/show\/NCT02767999"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0180|cit180","unstructured":"Cortical ischemic stroke and serotonin (CISS) www.clinicaltrials.gov\/ct2\/show\/NCT02865642"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0181|cit181","unstructured":"Fluoxetine Opens Window to improve motor recovery after stroke (FLOW) www.clinicaltrials.gov\/ct2\/show\/NCT03448159"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0182|cit182","unstructured":"Depression in hemorrhagic stroke www.clinicaltrials.gov\/ct2\/show\/NCT03826875"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0183|cit183","unstructured":"Randomized controlled trial of fluoxetine or placebo on quality of life after acute ischemic stroke www.thaiclinicaltrials.org\/show\/TCTR20181216001"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003690.pub4","article-title":"Pharmaceutical interventions for emotionalism after stroke","author":"Allida","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0185|cit185","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10 : Analysing data and performing metaanalyses. In: Higgins JP , Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al( editor s) . ) , Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021) Cochrane 2021 Available at www.training.cochrane.org\/handbook"},{"issue":"7109","key":"10.1002\/14651858.CD009286.pub4-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"10053","key":"10.1002\/14651858.CD009286.pub4-BIB0187|cit187","first-page":"1545-602","article-title":"Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0188|cit188","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0189|cit189","unstructured":"McMaster University (developed by Evidence Prime, Inc.) GRADEpro Guideline Development Tool [Software] 2015"},{"issue":"5","key":"10.1002\/14651858.CD009286.pub4-BIB0190|cit190","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0191|cit191","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD009286.pub4-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2471\/BLT.16.181636","article-title":"Stroke: a global response is needed","volume":"94","author":"Johnson","year":"2016","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00702-003-0100-0","article-title":"State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations","volume":"111","author":"Lang","year":"2004","journal-title":"Journal of Neural Transmission"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0194|cit194","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009286.pub3","article-title":"Selective serotonin reuptake inhibitors for stroke recovery","author":"Legg","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jad.2020.02.005","article-title":"Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: a network meta-analysis","volume":"266","author":"Zhang","year":"2020","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/jnr.21899","article-title":"Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect","volume":"87","author":"Lim","year":"2009","journal-title":"Journal of Neuroscience Research"},{"issue":"12","key":"10.1002\/14651858.CD009286.pub4-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00004647-199912000-00010","article-title":"Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks","volume":"19","author":"Loubinoux","year":"1999","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0198|cit198","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"Journal of the National Cancer Institute"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1186\/s13063-020-04875-1","article-title":"Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis","volume":"21","author":"Mead","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","article-title":"Adult neurogenesis in the mammalian central nervous system","volume":"28","author":"Ming","year":"2005","journal-title":"Annual Review of Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD009286.pub4-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"751-3","DOI":"10.1503\/cmaj.080820","article-title":"Does analysis using \u201clast observation carried forward\u201d introduce bias in dementia research?","volume":"179","author":"Molnar","year":"2008","journal-title":"CMAJ"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0202|cit202","unstructured":"NHS Side effects-selective serotonin reuptake inhibitors (SSRI) www.nhs.uk"},{"issue":"4","key":"10.1002\/14651858.CD009286.pub4-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02245579","article-title":"Up-regulation of beta l-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments","volume":"115","author":"Laakso","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0204|cit204","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3389\/fnins.2017.00637","article-title":"SSRI and motor recovery in stroke: reestablishment of inhibitory neural network tonus","volume":"11","author":"Pinto","year":"2017","journal-title":"Frontiers in Neuroscience"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0205|cit205","unstructured":"The Cochrane Collaboration Review Manager 5 (RevMan 5) 2020"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0206|cit206","first-page":"805","article-title":"Requirement of hippocampal neurogenesis antidepressant treatments and animal models of depressive-like behaviour","volume":"301","author":"Santarelli","year":"2003","journal-title":"Behavioural Pharmacology"},{"issue":"5-6","key":"10.1002\/14651858.CD009286.pub4-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/FBP.0b013e3282ee2aa8","article-title":"The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behaviour","volume":"18","author":"Schmidt","year":"2007","journal-title":"Behavioural Pharmacology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0208|cit208","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Akl E Guyatt GH on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group Chapter 11: Completing \u2018Summary of findings\u2019 tables and grading the confidence in or quality of the evidence. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4196\/kjpp.2009.13.3.257","article-title":"Fluoxetine and sertraline attenuate postischemic brain injury in mice","volume":"13","author":"Shin","year":"2009","journal-title":"Korean Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0210|cit210","unstructured":"Sterne JA Egger M Moher D Boutron I Chapter 10: Addressing reporting biases. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD009286.pub4-BIB0211|cit211","first-page":"9","article-title":"Adult neurogenesis and neuroplasticity","volume":"24","author":"Taupin","year":"2006","journal-title":"Restorative Neurology and Neuroscience"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"7-8","key":"10.1002\/14651858.CD009286.pub4-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.neuint.2007.04.011","article-title":"Repairing brain after stroke: a review on post-ischaemic neurogenesis","volume":"50","author":"Wiltrout","year":"2007","journal-title":"Neurochemistry International"},{"key":"10.1002\/14651858.CD009286.pub4-BIB0214|cit214","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41392-019-0064-7","article-title":"The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer\u2019s disease and vascular dementia: focusing on fluoxetine with long follow-up periods","volume":"4","author":"Xie","year":"2019","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"9","key":"10.1002\/14651858.CD009286.pub4-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/j.1742-1241.2010.02437.x","article-title":"Fluoxetine for the prophylaxis of post-stroke depression in patients with stroke: a meta-analysis","volume":"64","author":"Yi","year":"2010","journal-title":"International Journal of Clinical Practice"},{"issue":"3","key":"10.1002\/14651858.CD009286.pub4-BIB0216|cit216","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1177\/1545968307312173","article-title":"Citalopram improves dexterity in chronic stroke patients","volume":"22","author":"Zittel","year":"2008","journal-title":"Neurorehabilitation and Neural Repair"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0217|cit217","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009286.pub3","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery","author":"Legg","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009286.pub4-BIB0218|cit218","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009286","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke","author":"Mead","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009286.pub4-BIB0219|cit219","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009286.pub2","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery","author":"Mead","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T21:22:03Z","timestamp":1667078523000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009286.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":219,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009286.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}